long half-life and large variability [Regulatives / Guidelines]

posted by martin  – Austria, 2020-07-29 18:57 (1033 d 03:50 ago) – Posting: # 21798
Views: 2,711

Dear all,

I would appreciate the forum members thoughts on the following situation.

In short:My interpretation of regulatoy guidelines: adding additional fixed effect factors to the factors mentioned in the guidelines is typically considered as not acceptable by regulators.

best regards & looking forward to some ideas to potentially address this situation

martin

Complete thread:

UA Flag
Activity
 Admin contact
22,614 posts in 4,740 threads, 1,609 registered users;
23 visitors (0 registered, 23 guests [including 13 identified bots]).
Forum time: 22:47 CEST (Europe/Vienna)

For every fact
there is an infinity of hypotheses.    Robert M. Pirsig

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5